Kaufman is working to develop new, more potent and specific therapies for the disease, focusing on novel compounds to enhance fluid drainage from the eye, and others to protect retinal ganglion cells and their axons from pressure-induced damage. This is the latest in a string of awards given to the UW's Department of Ophthalmology and Visual sciences. The UW was chosen for the competitive GRF award by a panel of ophthalmology experts not connected to the applying institutions. Kaufman attributes the award in large part to a strong collaborative team of basic researchers, clinical investigators and epidemiologists. Each researcher focuses on a specific aspect of the disease that hopefully someday will fit together to form a picture of how to best prevent glaucoma, which afflicts more than two million Americans.
Coverage includes biomedicine, behavior, conservation and veterinary science.
P-T Research Highlights are supported by a grant from the National Institutes of Health, National Center for Research Resources. Copyright 1998, Wisconsin Regional Primate Research Center. No portion of this highlight may be copied or redistributed without the consent of the editor.